What is the recommended treatment for scabies in an otherwise healthy individual?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Scabies

First-Line Treatment Recommendation

Permethrin 5% cream applied from the neck down (or scalp-to-toes in infants, elderly, and immunocompromised patients) and washed off after 8-14 hours is the preferred first-line treatment for scabies in otherwise healthy individuals. 1, 2, 3, 4


Primary Treatment Options

Permethrin 5% Cream (Preferred)

  • Apply to all body areas from neck down and wash off after 8-14 hours 1, 4
  • One application is generally curative in uncomplicated cases 4
  • Approximately 30 grams is sufficient for an average adult 4
  • More effective, safer, and less expensive than ivermectin for standard scabies 1
  • Cure rate of 96.9% with two applications one week apart 5

Special application considerations:

  • Infants, elderly, and immunocompromised patients require scalp-to-toes application including hairline, neck, temple, and forehead 1, 4, 6
  • Apply under fingernails after trimming them short 7, 8
  • The scalp is rarely infested in healthy adults but commonly affected in vulnerable populations 4, 6

Oral Ivermectin (Alternative First-Line)

  • Dosage: 200 μg/kg body weight, repeated in 2 weeks 1, 2, 3
  • Must be taken with food to increase bioavailability and epidermal penetration 1, 3
  • Single dose provides 62.4% cure rate; two doses at 2-week interval increases efficacy to 92.8% 5
  • The second dose is essential because ivermectin has limited ovicidal activity and does not kill eggs present at initial treatment 1, 3
  • No dosage adjustments needed for renal impairment, but safety uncertain in severe liver disease 1

Preferred situations for ivermectin:

  • Crusted (Norwegian) scabies 1, 3, 9
  • Immunocompromised patients 2, 9
  • Institutional outbreaks 2, 8
  • Bedridden patients 8

Alternative Treatment Options (When First-Line Fails or Unavailable)

Lindane 1% (Use Only as Last Resort)

  • Apply thin layer from neck down, wash off after 8 hours 1, 2
  • Should only be used if patient cannot tolerate recommended therapies or these have failed 1
  • Contraindicated in: children <10 years, pregnant/lactating women, persons with extensive dermatitis 1, 2, 3
  • Never apply after bathing as this increases absorption and seizure risk 1, 2, 3
  • Risk of neurotoxicity, seizures, and aplastic anemia 1, 3
  • Resistance reported in some U.S. regions 1

Other Alternatives

  • Sulfur 6% ointment: Apply nightly for 3 nights, washing off previous applications before reapplying 2
  • Crotamiton 10%: Apply nightly for 2 consecutive nights, wash off 24 hours after second application 2, 7
  • Benzyl benzoate 25%: 87% cure rate but causes burning sensation in 43% of patients; used internationally when permethrin unavailable 2, 10

Special Populations

Pregnant and Lactating Women

  • Permethrin 5% cream is the preferred treatment 1, 2, 3, 10
  • Ivermectin classified as "human data suggest low risk" in pregnancy and probably compatible with breastfeeding 1
  • Avoid lindane due to association with neural tube defects, mental retardation, and accumulation in placenta/breast milk 1

Infants and Young Children

  • Permethrin is recommended 1, 2, 3
  • Must include scalp, temple, and forehead in application 1, 4
  • Never use lindane in children <10 years due to neurotoxicity risk 1, 2, 3

Crusted (Norwegian) Scabies

Requires aggressive combination therapy due to massive mite burden (thousands to millions of mites) 2, 3:

  • Permethrin 5% cream applied daily for 7 days, then twice weekly until cure 2, 3
  • PLUS oral ivermectin 200 μg/kg on days 1,2,8,9, and 15 2, 3
  • The multiple-dose ivermectin schedule addresses limited ovicidal activity and massive mite burden 3
  • Single-application permethrin or single-dose ivermectin will fail 3
  • Most common in immunodeficient, debilitated, or malnourished persons 3

Environmental and Contact Management

Decontamination (Critical to Prevent Reinfection)

  • Machine wash and dry bedding/clothing using hot cycle, dry clean, or remove from body contact for at least 72 hours 1, 2, 3, 10
  • Vacuum furniture and carpets 8
  • Isolate non-launderable items for minimum 2 days (or 3 weeks for rigorous approach) 8
  • Fumigation of living areas is unnecessary 1, 2, 3
  • Keep fingernails closely trimmed to reduce injury from scratching 1, 2

Contact Treatment

  • Examine and treat all persons with sexual, close personal, or household contact within the preceding month 1, 2, 3, 10
  • All contacts must be treated simultaneously to prevent reinfection 1, 8
  • For institutional outbreaks, treat entire at-risk population and consult expert 2
  • Avoid sexual contact until patients and partners treated, bedding decontaminated, and reevaluation completed 1

Follow-Up and Retreatment

Expected Post-Treatment Course

  • Pruritus may persist for up to 2 weeks after successful treatment and is rarely a sign of treatment failure 2, 3, 10, 4
  • This persistent itching represents sensitization reaction, not active infestation 1, 4
  • Persistent pruritus alone is NOT an indication for retreatment 4

Retreatment Criteria

  • Retreatment indicated if live mites observed after 14 days 4
  • Evaluate after 1 week if symptoms persist 1, 3
  • Consider retreatment after 2 weeks if: symptoms persist beyond 2 weeks, live mites observed, or other signs of treatment failure present 2, 3
  • If no response to one regimen, switch to alternative regimen 1

Common Reasons for Treatment Failure

  • Failure to treat all close contacts simultaneously 2, 3
  • Inadequate application of topical treatments (missing body areas, especially scalp in vulnerable populations) 2, 3, 8
  • Not repeating ivermectin dose after 2 weeks 2, 3
  • Reinfection from untreated contacts or fomites 2, 3, 8
  • Medication resistance 1, 8
  • Application errors (failure to treat face/scalp, failure to reapply medication) 8

Critical Pitfalls to Avoid

  • Do not use lindane after bathing or showering (increases absorption and seizure risk) 1, 2, 3
  • Do not use lindane in contraindicated populations (children <10 years, pregnant/lactating women, extensive dermatitis) 1, 2, 3
  • Do not skip scalp/face application in infants, elderly, or immunocompromised patients 1, 4, 6
  • Do not forget the second ivermectin dose at 2 weeks 1, 2, 3
  • Do not retreat based solely on persistent itching within 2 weeks 2, 3, 10, 4
  • Do not fail to treat all household and close contacts simultaneously 1, 2, 3, 8

Secondary Bacterial Infection

  • Staphylococcus aureus is the most common secondary bacterial pathogen in impetiginized scabies 11
  • Streptococcus pyogenes also commonly causes secondary infection 11
  • Combination of permethrin 5% and fusidic acid 2% cream is more effective than permethrin alone for impetiginized scabies (95% vs 35% efficacy at day 14) 11

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Scabies Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Scabies Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Diagnosis and treatment of scabies: a practical guide.

American journal of clinical dermatology, 2002

Guideline

Benzyl Benzoate for Scabies Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.